Literature DB >> 2223105

Myofibroblasts and subepithelial fibrosis in bronchial asthma.

C E Brewster1, P H Howarth, R Djukanovic, J Wilson, S T Holgate, W R Roche.   

Abstract

A thickened bronchial epithelial basement membrane has long been regarded as a histopathologic characteristic of bronchial asthma. As we had previously demonstrated that this phenomenon is due to the deposition of interstitial collagens and fibronectin, we have now sought to determine the nature of the cell responsible for this process by studying endobronchial biopsies from eight normal and seven asthmatic volunteers by immunohistochemistry and electron microscopy. Biopsies were stained with PR 2D3, a monoclonal antibody to myofibroblasts of the pericrypt sheath of the colon and a monoclonal antibody to alpha-smooth muscle actin. The thickness of the subepithelial collagen and the organelle content of the cells therein were determined by electron microscopy. The subepithelial collagen thickness in the normal subjects ranged from 2.16 to 6.26 microns, while that in the asthmatic subjects ranged from 3.75 to 11.1 microns (Mann-Whitney test; P = 0.05). Elongated cells in the collagen layer were identified by staining with PR 2D3. As this antibody also stains smooth muscle, consecutive frozen sections were stained for alpha-smooth muscle actin and the number of positive cells per millimeter of basement membrane was subtracted from the count for PR 2D3. This yielded a count of 4.9 to 9.4 cells/mm in the normal subjects and 11.9 to 20.6 cells/mm in the asthmatics (P = 0.001). There was a highly significant correlation between the depth of subepithelial collagen and the number of PR 2D3-positive, alpha-smooth muscle actin-positive cells (Spearman rank correlation; r = 0.764 and P = 0.006). Electron microscopy confirmed the myofibroblastic nature of these cells.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2223105     DOI: 10.1165/ajrcmb/3.5.507

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  128 in total

Review 1.  Airway remodeling in asthma.

Authors:  J A Elias; Z Zhu; G Chupp; R J Homer
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

Review 2.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

3.  Contraction of fibroblast-containing collagen gels: initial collagen concentration regulates the degree of contraction and cell survival.

Authors:  Y K Zhu; T Umino; X D Liu; H J Wang; D J Romberger; J R Spurzem; S I Rennard
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-01       Impact factor: 2.416

Review 4.  Pathophysiological mechanisms of asthma. Application of cell and molecular biology techniques.

Authors:  K F Chung; I M Adcock
Journal:  Mol Biotechnol       Date:  2001-07       Impact factor: 2.695

5.  Mechanical stress is communicated between different cell types to elicit matrix remodeling.

Authors:  M A Swartz; D J Tschumperlin; R D Kamm; J M Drazen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

Review 6.  New evidence of inflammation in asthma.

Authors:  A M Vignola; R Gagliardo; D Guerrera; G Chiappara; P Chanez; J Bousquet; G Bonsignore
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

7.  Cultured lung fibroblasts from ovalbumin-challenged "asthmatic" mice differ functionally from normal.

Authors:  Hisatoshi Sugiura; Xiangde Liu; Fenghai Duan; Shin Kawasaki; Shinsaku Togo; Koichiro Kamio; Xing Qi Wang; Lijun Mao; Youngsoo Ahn; Ronald F Ertl; Tom W Bargar; Abdo Berro; Thomas B Casale; Stephen I Rennard
Journal:  Am J Respir Cell Mol Biol       Date:  2007-06-15       Impact factor: 6.914

Review 8.  The pharmacological modulation of allergen-induced asthma.

Authors:  L L Ma; Paul M O'Byrne
Journal:  Inflammopharmacology       Date:  2012-10-25       Impact factor: 4.473

Review 9.  Matrix remodeling in chronic lung diseases.

Authors:  Bon-Hee Gu; Matthew C Madison; David Corry; Farrah Kheradmand
Journal:  Matrix Biol       Date:  2018-03-17       Impact factor: 11.583

Review 10.  Definition of critical asthma syndromes.

Authors:  Nicholas Kenyon; Amir A Zeki; Timothy E Albertson; Samuel Louie
Journal:  Clin Rev Allergy Immunol       Date:  2015-02       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.